Evaluation of Patients with Symptoms Suggestive of Chronic Polyneuropathy
Overview
Physiology
Authors
Affiliations
Objectives: The aim of this study was to determine the diagnostic yield and to describe the spectrum of diagnosis encountered by evaluation of patients with symptoms suggestive of chronic polyneuropathy.
Methods: We prospectively evaluated 198 patients referred to a department of neurology with symptoms suggestive of polyneuropathy. The evaluation included nerve conduction studies with near-nerve technique, quantitative examination of temperature sensation, blood tests, chest x-rays, and skin biopsies as well as diagnostic tests for differential diagnoses.
Results: Polyneuropathy was found in 147 patients, alternative diagnoses in 25, and 26 remained undiagnosed. The etiology of polyneuropathy could not be identified in 25% of the patients with polyneuropathy. In the remaining 75%, the cause of neuropathy was diabetes and/or alcohol abuse (41%), monoclonal gammopathy of undetermined significance (5%), drugs (5%), connective tissue disease (3%), and a number of less frequent conditions. A previously undiagnosed condition was found in 30% of the patients with polyneuropathy.
Conclusion: Evaluation of patients with symptoms suggestive of polyneuropathy reveals a high fraction of patients with previously undiagnosed conditions both in patients ending up with a polyneuropathy diagnosis and those without this diagnosis.
Knowledge gaps in diagnosing chronic polyneuropathy: Review of national guidelines.
Wiersma M, van der Star G, Notermans N, van Doorn P, Vrancken A J Peripher Nerv Syst. 2024; 29(4):383-392.
PMID: 39473054 PMC: 11625971. DOI: 10.1111/jns.12667.
Augustus Waller's foresight realized: SARM1 in peripheral neuropathies.
Geisler S Curr Opin Neurobiol. 2024; 87:102884.
PMID: 38852438 PMC: 11600426. DOI: 10.1016/j.conb.2024.102884.
Daeschler S, Pennekamp A, Tsilingiris D, Bursacovschi C, Aman M, Eisa A J Pers Med. 2023; 13(2).
PMID: 36836582 PMC: 9962788. DOI: 10.3390/jpm13020348.
Foretinib mitigates cutaneous nerve fiber loss in experimental diabetic neuropathy.
Daeschler S, Zhang J, Gordon T, Borschel G, Feinberg K Sci Rep. 2022; 12(1):8444.
PMID: 35589940 PMC: 9120083. DOI: 10.1038/s41598-022-12455-3.
Stefaniak A, Agelopoulos K, Bednarska-Chabowska D, Mazur G, Stander S, Szepietowski J Acta Derm Venereol. 2022; 102:adv00719.
PMID: 35535640 PMC: 9631289. DOI: 10.2340/actadv.v102.933.